JANUS HENDERSON GROUP PLC

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. The latest filing for each security since 12/18/2024, newest first.

Issuer % of Class Filed
Larimar Therapeutics, Inc. 13G/A
LRMR · 517125100
 0% 8/14/2025
Event 3/31/2025
Omniab, Inc. 13G/A
OABI · 68218J103
 0.8% 8/14/2025
Event 6/30/2025
Entrada Therapeutics, Inc. 13G/A
TRDA · 29384C108
 4.0% 8/14/2025
Event 6/30/2025
The Beauty Health Company 13G/A
SKIN · 88331L108
 4.5% 8/14/2025
Event 6/30/2025
Walker & Dunlop, Inc. 13G/A
WD · 93148P102
 4.6% 8/14/2025
Event 6/30/2025
Globus Medical, Inc. 13G/A
GMED · 379577208
 6.1% 5/14/2025
Event 3/31/2025
Mereo Biopharma Group PLC 13G/A
MREO · 589492107
 14.3% 5/14/2025
Event 3/31/2025
Cargo Therapeutics, Inc. 13G/A
CRGX · 14179K101
 0% 5/14/2025
Event 3/31/2025
Immunome Inc 13G/A
IMNM · 45257U108
 2.2% 5/14/2025
Event 3/31/2025
Zai Lab Ltd 13G/A
G9887T116
 3.6% 5/14/2025
Event 3/31/2025
Blackbaud, Inc. 13G/A
BLKB · 09227Q100
 4.3% 5/14/2025
Event 3/31/2025
Perspective Therapeutics Inc 13G/A
CATX · 46489V302
 0% 2/14/2025
Event 12/31/2024
Applied Therapeutics Inc 13G/A
APLT · 03828A101
 0% 2/14/2025
Event 12/31/2024
Pepgen Inc 13G/A
PEPG · 713317105
 1.6% 2/14/2025
Event 12/31/2024
Caesars Entertainment Inc 13G/A
CZR · 12769G100
 3.3% 2/14/2025
Event 12/31/2024
Precision BioSciences, Inc. 13G/A
DTIL · 74019P207
 0% 2/14/2025
Event 12/31/2024
Neogenomics Inc 13G/A
NEO · 64049M209
 4.8% 2/14/2025
Event 12/31/2024
Neurogene Inc. 13G/A
NGNE · 64135M105
 0% 2/14/2025
Event 12/31/2024
CytomX Therapeutics, Inc. 13G/A
CTMX · 23284F105
 0% 2/14/2025
Event 12/31/2024